R. Gregg Stone

ZetrOZ Systems is a healthcare technology company developing the latest soft tissue healing therapeutics. The company has deep research partnerships with the US Government to develop bioelectronic systems for the delivery of Sustained Acoustic Medicine, combined with activation of Mechanobiology, Pharmacology and Human Physiology. As a global healthcare company serving millions of patients, our proprietary medical technology platforms are specially designed and formulated for the treatment of acute and chronic musculoskeletal conditions, and our innovations are clinically proven to enhance tissue recovery, accelerate the body’s natural healing processes, and relieve pain. sam® delivers Sustained Acoustic Medicine safely in the home for the treatment of select medical conditions such as the relief of pain, the relief of muscle spasm, the treatment of joint contracture and the local increase in circulation.

TruTouch Technologies develops and manufactures revolutionary technology for how we measure - in real time -the condition of the human body. The non-invasive, light-based device used reflected light to achieve fast and accurate results. Our technology is the product of over 20 years of research and 65 world-wide patents and patent applications, multiple generations of product, and millions of real-world tests, with next-generation product being deployed in a trial vehicle fleet in late 2018. TruTouch is currently developing the next generation of alcohol detection sensors for use in vehicles under the DADSS (www.DADSS.org) program. The DADSS research program brings together the National Highway Traffic Safety Adminstration (NHTSA) and the Automotive Coalition for Traffic Safety (ACTS) to collaborate and translate TruTouchs technology into vehicular components and expand the touch-based sensor applications.

CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia. The company’s FDA-approved HeartLight Endoscopic Ablation System has successfully treated more than 10,000 patients in the United States, Europe and Japan. The HeartLight System is a revolutionary catheter ablation technology that along with direct visualization and titratable laser energy, represents a new standard for AFib ablation. CardioFocus is headquartered in Marlborough, MA. For more information, visit www.CardioFocus.com. Social Media Community Guidelines: bit.ly/2IDIBZR

ZetrOZ Systems is a healthcare technology company developing the latest soft tissue healing therapeutics. The company has deep research partnerships with the US Government to develop bioelectronic systems for the delivery of Sustained Acoustic Medicine, combined with activation of Mechanobiology, Pharmacology and Human Physiology. As a global healthcare company serving millions of patients, our proprietary medical technology platforms are specially designed and formulated for the treatment of acute and chronic musculoskeletal conditions, and our innovations are clinically proven to enhance tissue recovery, accelerate the body’s natural healing processes, and relieve pain. sam® delivers Sustained Acoustic Medicine safely in the home for the treatment of select medical conditions such as the relief of pain, the relief of muscle spasm, the treatment of joint contracture and the local increase in circulation.

TruTouch Technologies develops and manufactures revolutionary technology for how we measure - in real time -the condition of the human body. The non-invasive, light-based device used reflected light to achieve fast and accurate results. Our technology is the product of over 20 years of research and 65 world-wide patents and patent applications, multiple generations of product, and millions of real-world tests, with next-generation product being deployed in a trial vehicle fleet in late 2018. TruTouch is currently developing the next generation of alcohol detection sensors for use in vehicles under the DADSS (www.DADSS.org) program. The DADSS research program brings together the National Highway Traffic Safety Adminstration (NHTSA) and the Automotive Coalition for Traffic Safety (ACTS) to collaborate and translate TruTouchs technology into vehicular components and expand the touch-based sensor applications.

CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AFib), the most common heart arrhythmia. The company’s FDA-approved HeartLight Endoscopic Ablation System has successfully treated more than 10,000 patients in the United States, Europe and Japan. The HeartLight System is a revolutionary catheter ablation technology that along with direct visualization and titratable laser energy, represents a new standard for AFib ablation. CardioFocus is headquartered in Marlborough, MA. For more information, visit www.CardioFocus.com. Social Media Community Guidelines: bit.ly/2IDIBZR